IRIS
SARMATI, LOREDANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 56.270
AS - Asia 7.541
EU - Europa 6.407
SA - Sud America 1.336
AF - Africa 142
OC - Oceania 94
Continente sconosciuto - Info sul continente non disponibili 25
Totale 71.815
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 56.029
SG - Singapore 3.631
IT - Italia 1.513
CN - Cina 1.397
BR - Brasile 1.130
DE - Germania 1.001
HK - Hong Kong 889
IE - Irlanda 707
UA - Ucraina 700
KR - Corea 670
RU - Federazione Russa 445
GB - Regno Unito 406
SE - Svezia 404
VN - Vietnam 307
FR - Francia 283
FI - Finlandia 242
PL - Polonia 193
CA - Canada 145
IN - India 133
NL - Olanda 118
ES - Italia 95
AT - Austria 87
AU - Australia 85
JP - Giappone 81
ID - Indonesia 75
BE - Belgio 74
MX - Messico 73
AR - Argentina 70
BD - Bangladesh 60
ZA - Sudafrica 53
TR - Turchia 50
CZ - Repubblica Ceca 49
IQ - Iraq 48
PK - Pakistan 35
CO - Colombia 28
EC - Ecuador 27
CL - Cile 23
KG - Kirghizistan 20
LT - Lituania 20
VE - Venezuela 20
IL - Israele 17
MA - Marocco 17
UZ - Uzbekistan 16
CH - Svizzera 15
PY - Paraguay 15
EU - Europa 14
IR - Iran 13
AE - Emirati Arabi Uniti 12
EG - Egitto 12
KE - Kenya 12
KZ - Kazakistan 12
TN - Tunisia 12
TW - Taiwan 12
JO - Giordania 11
PE - Perù 11
RO - Romania 10
SA - Arabia Saudita 10
NZ - Nuova Zelanda 9
PH - Filippine 9
DZ - Algeria 7
ET - Etiopia 7
GR - Grecia 7
UY - Uruguay 7
HN - Honduras 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AL - Albania 5
BA - Bosnia-Erzegovina 5
BH - Bahrain 5
SC - Seychelles 5
BG - Bulgaria 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
LB - Libano 4
NO - Norvegia 4
NP - Nepal 4
PT - Portogallo 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
AZ - Azerbaigian 3
JM - Giamaica 3
MD - Moldavia 3
OM - Oman 3
TT - Trinidad e Tobago 3
TZ - Tanzania 3
CM - Camerun 2
GA - Gabon 2
HR - Croazia 2
HU - Ungheria 2
KH - Cambogia 2
LV - Lettonia 2
MK - Macedonia 2
MN - Mongolia 2
MY - Malesia 2
PA - Panama 2
QA - Qatar 2
RS - Serbia 2
SS - ???statistics.table.value.countryCode.SS??? 2
AM - Armenia 1
BB - Barbados 1
Totale 71.799
Salva come PNG Salva come JPEG
Città #
Woodbridge 14.891
Wilmington 14.678
Houston 11.300
Fairfield 1.823
Singapore 1.780
Ann Arbor 1.390
Chandler 1.361
Ashburn 1.276
Hong Kong 879
Seattle 773
Beijing 686
Cambridge 630
Dublin 617
Jacksonville 589
Rome 569
New York 457
Medford 448
Dearborn 396
The Dalles 334
Santa Clara 321
Los Angeles 319
Lawrence 214
Buffalo 157
Dallas 154
Council Bluffs 150
Munich 145
San Diego 140
Milan 139
Kraków 121
São Paulo 119
Ho Chi Minh City 112
Nuremberg 99
Menlo Park 96
London 90
Moscow 85
Zhengzhou 84
Boardman 74
Brussels 73
Hanoi 73
Mülheim 72
Redondo Beach 69
Chicago 65
Tokyo 64
Helsinki 58
Warsaw 56
Denver 54
Orem 53
Jakarta 50
Brooklyn 49
Montreal 49
Toronto 48
Phoenix 47
Palo Alto 44
Guangzhou 43
Stockholm 42
Rio de Janeiro 41
San Mateo 39
Hangzhou 37
Falls Church 36
Johannesburg 36
San Francisco 34
San Jose 34
Chennai 33
Lappeenranta 33
Norwalk 33
Redwood City 33
Shanghai 32
Sydney 32
Brno 31
Engelhard 31
Frankfurt am Main 31
Hefei 31
Mexico City 29
Salt Lake City 29
Vienna 29
Washington 29
Amsterdam 28
Melbourne 28
Belo Horizonte 26
Nanjing 26
Ankara 25
Atlanta 25
Boston 25
Creede 25
Manchester 25
Mountain View 25
North Bergen 25
Seoul 25
Verona 25
Poplar 24
University Park 22
Columbus 21
Turku 21
Canberra 20
Kunming 20
Jinan 19
Naples 19
Baghdad 18
Brasília 18
Dhaka 17
Totale 59.750
Salva come PNG Salva come JPEG
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 557
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor 529
Microbiologic characteristics and predictors of mortality in bloodstream infections in intensive care unit patients: A 1-year, large, prospective surveillance study in 5 Italian hospitals 519
Leflunomide-induced DRESS syndrome 510
A randomized controlled study for the evaluation of the activity of a triple combination of zidovudine, thymosin-alpha(1) and interferon-alpha in HIV-infected individuals with CD4 counts between 200 and 500 cells/mm(3) 508
Emergence of KPC-producing Klebsiella pneumoniae in Italy 508
18-Fluoro-2-deoxyglucose positron emission tomography-computed tomography: an additional tool in the diagnosis of prosthetic valve endocarditis. 494
Human herpesvirus-8 infection in pregnancy and labor: Lack of evidence of vertical transmission 487
Clinical predictors and microbiology of ventilator-associated pneumonia in the intensive care unit: a retrospective analysis in six Italian hospitals 484
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 480
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression 469
Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy 468
Prognostic factors of long-term CD4+ count-guided interruption of antiretroviral treatment 467
A stable CC-chemokine receptor (CCR)-5 tropic virus is correlated with the persistence of HIV RNA at less than 2.5 copies in successfully treated naïve subjects. 464
Novelties in evaluation and monitoring of human immunodeficiency virus-1 infection: Is standard virological suppression enough for measuring antiretroviral treatment success? 462
Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimens 461
A relapsing inflammatory syndrome and active human herpesvirus 8 infection 461
Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naive to the antiretroviral drugs 459
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 453
Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing 452
HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (< 400 HIV-RNA cp/ml) during different antiretroviral regimens 450
Efficient and reproducible new semimicromethod for the detection and titration of HIV in human plasma 447
Infection with human herpesvirus type 8 and Kaposi's sarcoma in a central Italian area formerly endemic for malaria 446
Candida Albicans Peritoneal Infection in a patient with slerosing Encapsulating Peritonitis under continous peritoneal dialysis. Efficacy of intra-abdominal Amphotericin B and negative pressure after failure of a systemic therapy 441
Advances in herpesvirus diagnosis 439
A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient 439
HIV plasma viremia in 22 seropositive subjects [VALUTAZIONE DELLA VIREMIA PLASMATICA DA HIV IN 22 SOGGETTI SIERO-POSITIVI] 437
Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal 436
Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy 435
Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapy 434
Neutralizing antibodies against autologous human immunodeficiency virus type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment 431
Cortical sources of resting state electroencephalographic rhythms probe brain function in naïve HIV individuals 431
Correlation between changes in plasma HIV RNA levels and in plasma infectivity in response to antiretroviral therapy. 430
Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAART 429
Reduction of IFN-gamma and IL-2 production by peripheral lymphocytes of HIV-exposed seronegative subjects 427
Raltegravir plasma concentrations in treatment-experienced patients receiving salvage regimens based on raltegravir with and without maraviroc coadministration 425
Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations 424
A case of rhabdomiolysis associated with raltegravir use 423
High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission. 421
High prevalence of M184 mutation among patients with viroimmunologic discordant responses to highly active antiretroviral therapy and outcomes after change of therapy guided by genotypic analysis 420
Increase in neutralizing antibody titer against sequential autologous HIV-1 isolates after 16 weeks saquinavir (invirase) treatment 419
Human herpesvirus 8 and human herpesvirus 2 infections in prison population 418
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: impact on susceptibility to first-line strategies including Integrase strand-transfer inhibitors 418
Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy 417
Plasma Viremia Titration and RNA Quantitation in ICD-p24 Negative HIV Type-1-Infected Patients 417
HIV phenotype switching during antiretroviral therapy: emergence of saquinavir-resistant strains with less cytopathogenicity 417
Infection with human herpesvirus-8 and its correlation with hepatitis B virus and hepatitis C virus markers among rural populations in Cambodia 415
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 415
Five human immunodeficiency virus type 1 phenotypic variants with different MT-2 cell tropisms correlate with prognostic markers of disease 414
ellular proviral HIV-DNA decline and viral isolation in naïve subjects with <5000 copies/ml of HIV-RNA and >500 x 10(6)/l CD4 cells treated with highly active antiretroviral therapy. 413
Correlates of HIV, HBV, and HCV infections in a prison inmate population: Results from a multicentre study in Italy 412
Prevalence of HHV-8 infection in Albanian adults and association with HBV and HCV 409
Adherence and genotypic drug resistance mutations in HIV-1-infected patients failing current antiretroviral therapy 409
Complication of nasal piercing by Staphylococcus aureus endocarditis: a case report and a review of literature. 407
Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon 407
Prevalence trend and correlates of HHV-8 infection in HIV-infected patients 406
Viral growth assay to evaluate the replicative capacity of HIV-1 isolates 406
Dapsone hypersensitivity syndrome complicated by Scedosporium apiospermum pneumonia in an immunocompetent patient. 406
Human herpesvirus 8 cytoviraemia rebound in a patient with Kaposi's sarcoma after a short interruption of efficient antiretroviral therapy. 404
A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART. 403
Primary human herpesvirus 8 infection in immunocompetent children. 403
Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept study 402
HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro 401
KSHV DNA viremia correlates with low CD4+ cell count in Italian males at the time of diagnosis of HIV infection 399
Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity. 399
Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: A cross-sectional evaluation 398
Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors 396
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens 396
Infection with human herpesvirus type 8 and human T-cell leukaemia virus type 1 among individuals participating in a case-control study in Havana City, Cuba 395
Non-B HIV type 1 subtypes: Replicative capacity and response to antiretroviral therapy 393
null 393
Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS [1] 392
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 392
Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy 392
HBV, HCV, HDV AND HEV COINFECTIONS IN A COHORT OF HIV POSITIVE PATIENTS IN CAMEROON 391
HIV neutralizing antibody titer during structured treatment interruption of highly active antiretroviral therapy 390
HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia 390
Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages 389
Saquinavir delays the emergence of zidovudine resistance in HIV-1 seropositive patients treated with combination therapy. 388
Reply to 'Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non-nucleosides', by Barreiro et al. [2] 386
High rate of HIV isolation from plasma of asymptomatic patients through polyethylene glycol (PEG) treatment 385
Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy 384
HHV-8 infection in African children 384
Development of cellulitis caused by Aeromonas hydrophila in allogeneic hematopoietic transplantation: a case report. 383
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 383
High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians 382
Serological testing for human herpesvirus 8 381
Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation 379
Nevirapine use, prolonged antiretroviral therapy and high CD4 nadir values are strongly correlated with undetectable HIV-DNA and -RNA levels and CD4 cell gain. 379
Infection with human immunodeficiency virus, herpes simplex virus type 2, and human herpes virus 8 in remote villages of southwestern Papua New Guinea 379
Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: A systematic review 378
ISS-NIA Study Group. Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection. 378
Stavudine protective function and emergence of lamivudine resistance [4] (multiple letters) 378
Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. 377
Human immunodeficiency virus polymorphisms and zidovudine resistance 377
Human immunodeficiency virus polymorphisms and zidovudine resistance [3] (multiple letters) 377
Erysipeloid cutaneous metastasis from bladder carcinoma 376
Structural equation modelling of viral tropism reveals its impact on achieving viral suppression within 6 months in treatment-naive HIV-1-infected patients after combination antiretroviral therapy 372
Baseline cellular HIV DNA load predicts HIV DNA decline and residual HIV plasma levels during effective antiretroviral therapy. 369
Human immunodeficiency virus infection of human bone marrow stromal myoid cells 368
Totale 42.043
Salva come PNG Salva come JPEG
Categoria #
all - tutte 195.131
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 195.131
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.011 0 0 0 0 0 970 1.231 822 208 272 358 150
2021/20222.889 117 226 146 170 124 396 205 145 302 233 172 653
2022/20233.599 324 298 224 517 297 756 271 242 341 31 191 107
2023/20241.713 213 44 167 102 163 343 81 124 39 122 44 271
2024/20257.816 286 1.344 731 642 272 545 767 472 774 767 624 592
2025/20266.045 1.158 601 1.344 1.223 1.224 495 0 0 0 0 0 0
Totale 72.942